Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 20Carcinoma, Renal Cell 16Parkinson Disease 4, Autosomal Dominant Lewy Body 10Endometrial Neoplasms 7Neoplasms 4Biliary Tract Neoplasms 4Uterine Cervical Neoplasms 3Neuroendocrine Tumors 3Melanoma 3Liver Neoplasms 3Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Colorectal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2von Hippel-Lindau Disease 1Thyroid Carcinoma, Anaplastic 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Penile Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Kidney Neoplasms 1

Interventions

Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2Epirubicin 2pembrolizumab 1lenvatinib 1enfortumab vedotin 1anlotinib 1amivantamab 1Pemetrexed 1Observation 1Ipilimumab 1Imatinib Mesylate 1Glutamate Carboxypeptidase II 1Cyclophosphamide 1CTLA-4 Antigen 1Blood Specimen Collection 1BMS-906024 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Adenoid Cystic × lenvatinib × 90 days × Clear all
NCT02780310 2026-06-03

Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
33 enrolled

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡